Labcorp Holdings, Inc. (LH)
370.54
-1.78
(-0.48%)
USD |
NYSE |
Nov 13, 16:00
370.00
-0.54
(-0.15%)
After-Hours: 19:59
Labcorp Holdings Enterprise Value : 36.76B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 36.76B |
| November 11, 2026 | 36.76B |
| November 10, 2026 | 36.65B |
| November 09, 2026 | 36.72B |
| November 06, 2026 | 36.30B |
| November 05, 2026 | 36.03B |
| November 04, 2026 | 36.39B |
| November 03, 2026 | 35.27B |
| November 02, 2026 | 35.40B |
| October 30, 2026 | 35.88B |
| October 29, 2026 | 36.42B |
| October 28, 2026 | 35.78B |
| October 27, 2026 | 33.42B |
| October 26, 2026 | 33.32B |
| October 23, 2026 | 33.24B |
| October 22, 2026 | 33.32B |
| October 21, 2026 | 32.82B |
| October 20, 2026 | 32.77B |
| October 19, 2026 | 32.42B |
| October 16, 2026 | 32.35B |
| October 15, 2026 | 32.93B |
| October 14, 2026 | 32.30B |
| October 13, 2026 | 32.00B |
| October 12, 2026 | 32.15B |
| October 09, 2026 | 31.88B |
| Date | Value |
|---|---|
| October 08, 2026 | 32.04B |
| October 07, 2026 | 31.86B |
| October 06, 2026 | 31.84B |
| October 05, 2026 | 31.59B |
| October 02, 2026 | 31.58B |
| October 01, 2026 | 31.26B |
| September 30, 2026 | 31.55B |
| September 29, 2026 | 31.62B |
| September 28, 2026 | 31.68B |
| September 25, 2026 | 31.69B |
| September 24, 2026 | 31.63B |
| September 23, 2026 | 31.23B |
| September 22, 2026 | 31.84B |
| September 21, 2026 | 32.61B |
| September 18, 2026 | 32.59B |
| September 17, 2026 | 32.75B |
| September 16, 2026 | 32.89B |
| September 15, 2026 | 32.85B |
| September 14, 2026 | 32.15B |
| September 11, 2026 | 31.84B |
| September 10, 2026 | 31.47B |
| September 09, 2026 | 32.62B |
| September 08, 2026 | 32.92B |
| September 04, 2026 | 33.09B |
| September 03, 2026 | 33.46B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 34.45B |
| OPKO Health, Inc. | 1.314B |
| Myriad Genetics, Inc. | 645.88M |
| Fulgent Genetics, Inc. | 401.76M |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 263.10M |
| Revenue (Quarterly) | 3.81B |
| Total Expenses (Quarterly) | 3.547B |
| EPS Diluted (Quarterly) | 3.221 |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | 6.91% |
| Earnings Yield | 3.29% |
| Operating Earnings Yield | 5.38% |
| Normalized Earnings Yield | 3.614 |